International Patent: SIRNA TARGETING EXPRESSION OF ACTIVIN A RECEPTOR TYPE 1C (ACVR1C) GENE, AND CONJUGATE THEREOF AND USE THEREOF

GENEVA, June 19 -- LEADERNA THERAPEUTICS, LTD. filed a patent application (CN2025/135120) for “SIRNA TARGETING EXPRESSION OF ACTIVIN A RECEPTOR TYPE 1C (ACVR1C) GENE, AND CONJUGATE THEREOF AND USE THEREOF”. With publication no. WO/2026/103876, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....